EXCEL Clinical Trial (Universal Registry)

Abbott

Status: Completed

Conditions: Coronary Artery Disease; Myocardial Ischemia; Vascular Disease; Coronary Restenosis; Left Main Coronary Artery Disease; Coronary Artery Stenosis; Coronary Disease; Chronic Coronary Occlusion; Stent Thrombosis

Study type: Observational

Funder types: Industry

Identifiers

NCT01205789

10-389 UR

Details and patient eligibility

About

The purpose of the Universal Registry is to assess the proportion and reasons for which subjects with angiographically significant ULMCA disease requiring revascularization during the time course of this study are not randomized; to compare the baseline characteristics of subjects; and to assess the variability in randomization eligibility and treatment patterns.

Full description

Approximately 100 consecutive subjects who otherwise meet all enrollment criteria, will be analyzed separately as intermediate lesion subjects, and will be followed through the time of initial treatment per standard of care with intended PCI, CABG or medical treatment.

Enrollment: 1,000 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Subjects who are either not eligible for randomization or for other reasons are not randomized will be consented for the Universal Registry

Trial design

1,000 participants in 1 patient group

Universal Registry

Description:

Subjects who are either not eligible for randomization or for other reasons are not randomized will be consented for the Universal Registry